Yezli Saber, Yassin Yara, Mushi Abdulaziz, Bukhari Mamdouh, Banasser Talib, Khan Anas
The Global Centre for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Regional Laboratory, Makkah City General Directorate of Health Affairs, Ministry of Health, Makkah, Saudi Arabia.
Infect Drug Resist. 2022 Aug 23;15:4685-4696. doi: 10.2147/IDR.S375096. eCollection 2022.
Meningococcal disease and outbreaks are a risk during mass gatherings such as the Umrah religious pilgrimage to the Kingdom of Saudi Arabia (KSA). We aimed to investigate the carriage of among the 2019 Umrah pilgrims and determine the circulating serogroups and their antibiotic susceptibility profiles.
We conducted a cross-sectional study among adult Umrah pilgrims from 17th to 29th April 2019 in Mecca city, KSA. A questionnaire was administered to each participant, and an oropharyngeal swab was obtained. Microbiological techniques were used to isolate, identify and serogroup from the swabs. E-tests were used to determine the susceptibility of the isolates to nine antibiotics.
The study enrolled 616 pilgrims from 17 countries with a mean age of 53.8 years (±13.1, range = 19-91) and a male-to-female ratio of 1.1:1. Nearly 39% of the respondents had no formal education, 32.5% declared having an underlying health condition and 17.2% were current or past smokers. During their Umrah stay, most pilgrims reported sharing accommodation (98.5%) and never using a face mask (98.5%). Also, 34.6% reported suffering from influenza-like symptoms and 11.8% used antibiotics. was isolated from three pilgrims (carriage rate of 0.49%), two were serogroup A and one was serogroup B. Antibiotic susceptibility results were available for one isolate (serogroup B) which showed resistance to ciprofloxacin and decreased susceptibility to trimethoprim-sulfamethoxazole.
Carriage of among Umrah pilgrims was low. However, invasive serogroups were identified, including an isolate resistant to ciprofloxacin used for chemoprophylaxis. Meningococcal disease preventive measures for Umrah should be regularly reviewed and updated accordingly to reduce the risk of the disease and future pilgrimage-associated outbreaks.
在前往沙特阿拉伯王国进行朝觐宗教朝圣等大规模集会期间,存在脑膜炎球菌病及疫情爆发的风险。我们旨在调查2019年朝觐朝圣者中脑膜炎球菌的携带情况,并确定流行的血清群及其抗生素敏感性谱。
2019年4月17日至29日,我们在沙特阿拉伯王国麦加市对成年朝觐朝圣者进行了一项横断面研究。对每位参与者进行问卷调查,并采集咽拭子。采用微生物学技术从拭子中分离、鉴定脑膜炎球菌并确定其血清群。采用E试验确定分离株对9种抗生素的敏感性。
该研究纳入了来自17个国家的616名朝圣者,平均年龄为53.8岁(±13.1,范围=19 - 91岁),男女比例为1.1:1。近39%的受访者未接受过正规教育,32.5%宣称有基础健康状况,17.2%为当前或既往吸烟者。在朝觐期间,大多数朝圣者报告有合住情况(98.5%)且从未使用过口罩(98.5%)。此外,34.6%报告有流感样症状,11.8%使用过抗生素。从3名朝圣者中分离出脑膜炎球菌(携带率为0.49%),2例为A血清群,1例为B血清群。有1株分离株(B血清群)的抗生素敏感性结果显示对环丙沙星耐药,对甲氧苄啶 - 磺胺甲恶唑敏感性降低。
朝觐朝圣者中脑膜炎球菌的携带率较低。然而,已鉴定出侵袭性血清群,包括1株对用于化学预防的环丙沙星耐药的分离株。应定期审查和更新朝觐的脑膜炎球菌病预防措施,以降低疾病风险及未来与朝圣相关的疫情爆发风险。